These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 24286474)

  • 21. Anti-citrullinated fibronectin antibodies in rheumatoid arthritis are associated with human leukocyte antigen-DRB1 shared epitope alleles.
    van Beers JJ; Willemze A; Stammen-Vogelzangs J; Drijfhout JW; Toes RE; Pruijn GJ
    Arthritis Res Ther; 2012 Feb; 14(1):R35. PubMed ID: 22339947
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Peripheral distributions of IL-4-producing CD4 + T cells and CD4 + CD25 + FoxP3 + T cells (Tregs) in rheumatoid arthritis patients with poor response to therapy are associated with HLA shared epitope alleles and ACPA status.
    Tahamoli-Roudsari A; Tabatabaei R; Alvandpur N; Basiri Z; Behzad M; Rezaeepoor M; Abdolmaleki M; Fouladseresht H; Roshanaei G; Hajilooi M; Solgi G
    Immunol Res; 2022 Aug; 70(4):481-492. PubMed ID: 35445929
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thyroxin substitution and the risk of developing rheumatoid arthritis; results from the Swedish population-based EIRA study.
    Bengtsson C; Padyukov L; Källberg H; Saevarsdottir S
    Ann Rheum Dis; 2014 Jun; 73(6):1096-100. PubMed ID: 23613482
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of citrullinated vimentin peptides as T cell epitopes in HLA-DR4-positive patients with rheumatoid arthritis.
    Feitsma AL; van der Voort EI; Franken KL; el Bannoudi H; Elferink BG; Drijfhout JW; Huizinga TW; de Vries RR; Toes RE; Ioan-Facsinay A
    Arthritis Rheum; 2010 Jan; 62(1):117-25. PubMed ID: 20039411
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protective effect of HLA-DRB1*13 alleles during specific phases in the development of ACPA-positive RA.
    van Heemst J; Hensvold AH; Jiang X; van Steenbergen H; Klareskog L; Huizinga TW; van der Helm-van Mil A; Catrina AI; Toes RE; Lundberg K; van der Woude D
    Ann Rheum Dis; 2016 Oct; 75(10):1891-8. PubMed ID: 26715653
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic and environmental determinants for disease risk in subsets of rheumatoid arthritis defined by the anticitrullinated protein/peptide antibody fine specificity profile.
    Lundberg K; Bengtsson C; Kharlamova N; Reed E; Jiang X; Kallberg H; Pollak-Dorocic I; Israelsson L; Kessel C; Padyukov L; Holmdahl R; Alfredsson L; Klareskog L
    Ann Rheum Dis; 2013 May; 72(5):652-8. PubMed ID: 22661643
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anticitrullinated protein antibody (ACPA) in rheumatoid arthritis: influence of an interaction between HLA-DRB1 shared epitope and a deletion polymorphism in glutathione S-transferase in a cross-sectional study.
    Mikuls TR; Gould KA; Bynoté KK; Yu F; Levan TD; Thiele GM; Michaud KD; O'Dell JR; Reimold AM; Hooker R; Caplan L; Johnson DS; Kerr G; Richards JS; Cannon GW; Criswell LA; Noble JA; Bridges SL; Hughes L; Gregersen PK
    Arthritis Res Ther; 2010; 12(6):R213. PubMed ID: 21087494
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of the anti-citrullinated protein antibody repertoire prior to the onset of rheumatoid arthritis.
    van de Stadt LA; de Koning MH; van de Stadt RJ; Wolbink G; Dijkmans BA; Hamann D; van Schaardenburg D
    Arthritis Rheum; 2011 Nov; 63(11):3226-33. PubMed ID: 21792832
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New classification of the shared epitope in rheumatoid arthritis: impact on the production of various anti-citrullinated protein antibodies.
    Gyetvai A; Szekanecz Z; Soós L; Szabó Z; Fekete A; Kapitány A; Teodorescu M; Sipka S; Szegedi G; Lakos G
    Rheumatology (Oxford); 2010 Jan; 49(1):25-33. PubMed ID: 19920092
    [TBL] [Abstract][Full Text] [Related]  

  • 30.
    Hiwa R; Ikari K; Ohmura K; Nakabo S; Matsuo K; Saji H; Yurugi K; Miura Y; Maekawa T; Taniguchi A; Yamanaka H; Matsuda F; Mimori T; Terao C
    J Rheumatol; 2018 Apr; 45(4):470-480. PubMed ID: 29419463
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Peptidyl arginine deiminase type IV (PADI4) haplotypes interact with shared epitope regardless of anti-cyclic citrullinated peptide antibody or erosive joint status in rheumatoid arthritis: a case control study.
    Bang SY; Han TU; Choi CB; Sung YK; Bae SC; Kang C
    Arthritis Res Ther; 2010; 12(3):R115. PubMed ID: 20537173
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The HLA-DRB1 shared epitope alleles are primarily a risk factor for anti-cyclic citrullinated peptide antibodies and are not an independent risk factor for development of rheumatoid arthritis.
    van der Helm-van Mil AH; Verpoort KN; Breedveld FC; Huizinga TW; Toes RE; de Vries RR
    Arthritis Rheum; 2006 Apr; 54(4):1117-21. PubMed ID: 16572446
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Smoking increases rheumatoid arthritis susceptibility in individuals carrying the HLA-DRB1 shared epitope, regardless of rheumatoid factor or anti-cyclic citrullinated peptide antibody status.
    Bang SY; Lee KH; Cho SK; Lee HS; Lee KW; Bae SC
    Arthritis Rheum; 2010 Feb; 62(2):369-77. PubMed ID: 20112396
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Shared epitope defines distinct associations of cigarette smoking with levels of anticitrullinated protein antibody and rheumatoid factor.
    Ishikawa Y; Ikari K; Hashimoto M; Ohmura K; Tanaka M; Ito H; Taniguchi A; Yamanaka H; Mimori T; Terao C
    Ann Rheum Dis; 2019 Nov; 78(11):1480-1487. PubMed ID: 31427439
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gene-environment interaction between the DRB1 shared epitope and smoking in the risk of anti-citrullinated protein antibody-positive rheumatoid arthritis: all alleles are important.
    Lundström E; Källberg H; Alfredsson L; Klareskog L; Padyukov L
    Arthritis Rheum; 2009 Jun; 60(6):1597-603. PubMed ID: 19479873
    [TBL] [Abstract][Full Text] [Related]  

  • 36. How RA Associated HLA-DR Molecules Contribute to the Development of Antibodies to Citrullinated Proteins: The Hapten Carrier Model.
    Roudier J; Balandraud N; Auger I
    Front Immunol; 2022; 13():930112. PubMed ID: 35774784
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An investigation of the added value of an ACPA multiplex assay in an early rheumatoid arthritis setting.
    van Heemst J; Trouw LA; Nogueira L; van Steenbergen HW; van der Helm-van Mil AH; Allaart CF; Serre G; Holmdahl R; Huizinga TW; Toes RE; van der Woude D
    Arthritis Res Ther; 2015 Oct; 17():276. PubMed ID: 26437716
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnostic value of anti-cyclic citrullinated peptides and association with HLA-DRB1 shared epitope alleles in African rheumatoid arthritis patients.
    Singwe-Ngandeu M; Finckh A; Bas S; Tiercy JM; Gabay C
    Arthritis Res Ther; 2010; 12(2):R36. PubMed ID: 20196860
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Affinity Maturation of the Anti-Citrullinated Protein Antibody Paratope Drives Epitope Spreading and Polyreactivity in Rheumatoid Arthritis.
    Kongpachith S; Lingampalli N; Ju CH; Blum LK; Lu DR; Elliott SE; Mao R; Robinson WH
    Arthritis Rheumatol; 2019 Apr; 71(4):507-517. PubMed ID: 30811898
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The HLA-DRB1 shared epitope is not associated with antibodies against cyclic citrullinated peptide in Chinese patients with rheumatoid arthritis.
    Xue Y; Zhang J; Chen YM; Guan M; Zheng SG; Zou HJ
    Scand J Rheumatol; 2008; 37(3):183-7. PubMed ID: 18465452
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.